Journal of Medicinal Chemistry · 2016 · 45 citations · 22 references
Life SciencesMedicinal ChemistryMolecular BiologyDrug DesignMolecular VirologyVirologyAntiviral AgentsAntiviral PharmacologyEnzyme InhibitionRibonucleic Acid (Rna) ChemistryRna Polymerase FunctionViral Rna BiologyActive Site InhibitorsAntiviral Structure-activity RelationshipsIntegrase Strand Transfer InhibitorsNucleoside Reverse Transcriptase InhibitorsReverse Transcription Polymerase Chain Reaction (Rt-pcr)Structure - Activity Relationship OptimizationViral Polymerase InhibitorsViral Polymerases
Human immunodeficiency virus (HIV) reverse transcriptase (RT) associated ribonuclease H (RNase H) remains an unvalidated antiviral target. A major challenge of specifically targeting HIV RNase H arises from the general lack of selectivity over RT polymerase (pol) and integrase (IN) strand transfer (ST) inhibitions. We report herein the synthesis and biochemical evaluations of three novel 3-hydroxypyrimidine-2,4-dione (HPD) subtypes carefully designed to achieve selective RNase H inhibition. Biochemical studies showed the two subtypes with an N-1 methyl group (9 and 10) inhibited RNase H in low micromolar range without significantly inhibiting RT polymerase, whereas the N-1 unsubstituted subtype 11 inhibited RNase H in submicromolar range and RT polymerase in low micromolar range. Subtype 11 also exhibited substantially reduced inhibition in the HIV-1 INST assay and no significant cytotoxicity in the cell viability assay, suggesting that it may be amenable to further structure-activity relationship (SAR) for identifying RNase H inhibitors with antiviral activity.
22
Features and development of <i>Coot</i>
Paul Emsley, Bernhard Lohkamp, W. G. Scott et al. · Acta Crystallographica Section D Biological Crystallography · 2010 · 29.6K citations · Full text